⌘K

Login Start Free

Home/Filings/4/0001567619-23-002174

4//SEC Filing

Koppikar Utpal 4

Accession 0001567619-23-002174

CIK 0001604464other

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 5:00 PM ET

Size

4.8 KB

Accession

0001567619-23-002174

Insider Transaction Report

Form 4

Period: 2023-02-07

Atara Biotherapeutics, Inc.ATRA

Chief Financial Officer

Transactions

Sale
Common Stock
2023-02-07$5.46/sh−2,485$13,568→ 188,849 total

Footnotes (1)

[F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1

filerCIK 0001742696

Filing Metadata

Form type: 4
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 5:00 PM ET
Size: 4.8 KB

View on SEC.gov